↓ Skip to main content

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer

Overview of attention for article published in npj Breast Cancer, July 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 577)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
40 news outlets
blogs
1 blog
twitter
7 X users
wikipedia
1 Wikipedia page

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer
Published in
npj Breast Cancer, July 2023
DOI 10.1038/s41523-023-00564-9
Pubmed ID
Authors

Melinda Magna, Gyong Ha Hwang, Alec McIntosh, Katherine Drews-Elger, Masaru Takabatake, Adam Ikeda, Barbara J. Mera, Taekyoung Kwak, Philip Miller, Marc E. Lippman, Barry I. Hudson

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 20%
Student > Ph. D. Student 2 20%
Unknown 6 60%
Readers by discipline Count As %
Unspecified 2 20%
Biochemistry, Genetics and Molecular Biology 1 10%
Medicine and Dentistry 1 10%
Unknown 6 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 300. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2023.
All research outputs
#112,243
of 24,916,485 outputs
Outputs from npj Breast Cancer
#9
of 577 outputs
Outputs of similar age
#2,286
of 347,398 outputs
Outputs of similar age from npj Breast Cancer
#1
of 23 outputs
Altmetric has tracked 24,916,485 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 577 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,398 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.